Question 1

What is GMP Bio?

Accepted Answer

GMP Bio is a Entity.

Question 2

How often does GMP Bio appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 41 articles.

Question 3

When was GMP Bio first tracked by NewsDesk?

Accepted Answer

First tracked on Apr 06, 2026.

Question 4

When was GMP Bio last mentioned in news?

Accepted Answer

Last active on Jun 04, 2026.

Question 5

What is GMP Bio's current news sentiment?

Accepted Answer

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is GMP Bio in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving GMP Bio?

Accepted Answer

Oncotelic Therapeutics featured in BioMedWire (Jun 02, 2026, 6 articles).

Question 8

Who is GMP Bio most connected to?

Accepted Answer

Top relationships: Oncotelic Therapeutics, Oncotelic Therapeutics.

Question 9

How did the "Oncotelic Therapeutics featured in BioMedWire" event impact GMP Bio?

Accepted Answer

GMP Bio is a joint venture in which Oncotelic Therapeutics Inc. owns 45%, advancing its own pipeline of drug candidates that complement Oncotelic's strategic position.

Question 10

How did the "Nightfood, Oncotelic AI Robotics Joint Venture" event impact GMP Bio?

Accepted Answer

GMP Bio is a joint venture in which Oncotelic Therapeutics Inc. owns 45%, advancing its own pipeline of drug candidates that complement Oncotelic Therapeutics Inc.'s strategic position.

Question 11

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.